[ Back to EurekAlert! ]

Contact: William Davis
william_davis@med.unc.edu
919-966-5906 x254
University of North Carolina Health Care

Ethan Basch, University of North Carolina

Caption: The study, published Sept. 24 in Lancet Oncology, was led by Ethan Basch, M.D., director of the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center.

Credit: UNC Lineberger Comprehensive Cancer Center

Usage Restrictions: None

Related news release: Abiraterone acetate delays quality of life decline in men with metastatic prostate cancer


[ Back to EurekAlert! ]